INS and metabolic syndrome: The treatment with 4 U/day insulin avoided the dyslipidemia (Figure 3A,B) and the increases in biomarkers of glycoxidative stress, with the exception that HbA1c had a slight increase in DI4U rats when compared with the NYOG group (Figure 4A).